![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61B 5/145 | (2006.01) |
G05B 13/048 | (2013.01) | ||
A61B 5/00 | (2006.01) | ||
A61B 5/7275 | (2013.01) | ||
G05B 13/04 | (2006.01) | ||
G16H 50/20 | (2018.01) | ||
A61B 5/14532 | (2013.01) | ||
G16H 20/17 | (2018.01) |
(11) | Patento numeris | 3618713 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 18729226.3 |
Europos patento paraiškos padavimo data | 2018-05-03 | |
(97) | Europos patento paraiškos paskelbimo data | 2020-03-11 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-15 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2018/030771 |
Data | 2018-05-03 |
(87) | Numeris | WO 2018/204568 |
Data | 2018-11-08 |
(30) | Numeris | Data | Šalis |
201762501976 P | 2017-05-05 | US | |
201762536541 P | 2017-07-25 | US |
(72) |
HAIDAR, Ahmad Mohamad , US
|
(73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
(54) | CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE |
CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE |